Casdin Capital’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-520,000
| Closed | -$7.85M | – | 34 |
|
|
2017
Q2 | $7.85M | Buy |
520,000
+35,000
| +7% | +$529K | 2.9% | 13 |
|
|
2017
Q1 | $8.32M | Buy |
485,000
+210,000
| +76% | +$3.6M | 4.91% | 7 |
|
|
2016
Q4 | $3.33M | Sell |
275,000
-20,000
| -7% | -$242K | 2.75% | 14 |
|
|
2016
Q3 | $2.9M | Sell |
295,000
-45,000
| -13% | -$443K | 2.35% | 14 |
|
|
2016
Q2 | $3.48M | Sell |
340,000
-205,000
| -38% | -$2.1M | 3.47% | 14 |
|
|
2016
Q1 | $6.61M | Buy |
545,000
+212,500
| +64% | +$2.58M | 7.58% | 2 |
|
|
2015
Q4 | $5.33M | Buy |
+332,500
| New | +$5.33M | 4.71% | 12 |
|